Talk Abstracts
Wednesday, June 15
Precision probiotics and prebiotics.
Jens Walter, Ireland
Niv Zmora, Israel
The Then, Now, and Future of the “Biotics” Family. Eamonn Quigley, USA, Kristin Verbeke, Belgium and Clara Belzer, The Netherlands
All probiotic effects must be considered strain-specific. Hania Szajewska, Poland and Sarah Lebeer, Belgium
Personal predictions for the future of prebiotics (science only, don’t ask me about economy). Glenn Gibson, UK
Antiviral potential of topically applied lactobacilli in the respiratory tract: from mechanisms to application. Irina Spacova, Belgium
Human milk oligosaccharide-utilizing bifidobacteria produce immunomodulatory aromatic lactic acids in the infant gut. Martin Laursen, Denmark
Individual and group-based differences in gut microbiota responses to in vitro fiber interventions: Can mixtures of prebiotics contribute to harmonized beneficial effects? Frank Schuren, The Netherlands
Late Breaking News. Gregor Reid, Chair
Thursday, June 16
Discussion Group 1: The impact of diet on health benefits conferred by probiotics and prebiotics. Maria Marco, USA and Kevin Whelan, UK
Discussion Group 2: Probiotic acute and long term safety: where do we stand in 2022? Dan Merenstein and Mary Ellen Sanders, ISAPP
Discussion Group 3: What do we really know about the microbiome and health? Karen Scott, Scotland and Sarah Lebeer, Belgium
Discussion Group 4: The small intestinal microbiome – an ignored/undefined therapeutic target. Eamonn Quigley and Purna Kashyap, USA
Discussion Group 5: Establishing causality in probiotic and prebiotic intervention trials. Bob Hutkins, USA and Jens Walter, Ireland
Discussion Group 6: The status of ‘biotics’ in fermented foods. Gabriel Vinderola, Argentina and Kelly Swanson, USA
Unravelling health promoting microbiota-mediated mechanisms using metabolic profiling. Anisha Wijeyesekera, UK
Do prebiotics promote health through microbiota-mediated mechanisms? Michiel Kleerebezem, The Netherlands
Probiotics and chronic constipation: mechanisms of action and effectiveness. Eirini Dimidi, UK
Bacteria and bacteriophage – are they fighting or are they dancing? Colin Hill
A decade of research on Akkermansia muciniphila: what do we know now? Clara Belzer, The Netherlands
Regulatory perspectives on the first EFSA-approved novel food. Seppo Salminen, Finland
Friday, June 17
Pain in the NEC: Choosing the Right “Biotic” for Preterm Neonates. Geoff Preidis, USA
Microbiota and gas related complaints. Francisco Guarner, Spain
Prebiotic Galacto-oligosaccharides Impact Stool Frequency and Fecal Microbiota in Self-reported Constipated Adults: A Randomized Clinical Trial. Marieke Schoemaker, The Netherlands
Poster Abstracts
SFA Abstracts
1 – Riboflavin-overproducing Limosilactobacillus reuteri for biofortification of fermented foods. Sarah Ahannach, University of Antwerp, Belgium
2 – Honey varietals impact survivability of Bifidobacterium animalis ssp lactis in commercial yogurt through simulated in vitro digestion. David Alvarado, University of Illinois, USA
3 – Milk fermented by Lacticaseibacillus casei improve barrier function and alter sterol metabolism in intestinal epithelial cells. Glory Bui, University of California Davis, USA
4 – Physicochemical and microbiological evaluation of a probiotic carrot bio-yogurt stored under refrigeration conditions. Angel Camargo, Universidad Nacional de Colombia, Colombia
5 – In Silico study of efficiently producing fructooligosaccharides using a novel strain of Fusarium sp. HKF-74. Atul Chavan, CSIR-National Environmental Engineering Research Institute, India
6 – Extending probiotic science beyond human health: Design and application of a novel spray‐based formula for sustainable disease management in California honey bees. Brendan Daisley, University of Guelph, Canada
7 – Diversifying the offer of regional plant-based functinal foods: development of a probiotic fermented drink of beets and strawberries. Maria Florencia, Universidad Nacional del Litoral, Argentina
8 – Bacteriocin structural gene shuffling reveals multiple diverse structural gene homologues in the S. bovis/S. equinus complex pangenome. Daragh Hill, APC Microbiome Ireland, Ireland
9 – The bacteriocinogenic potential of the Hungate1000 culture collection of rumen isolated micro-organisms. David Hourigan, University College Cork, Ireland
10 – Integrative multi-omics analyses reveal the therapeutic impact of probiotics via modulating microbial-based signatures in chronic kidney disease. Hsiao-Wen Huang, National Taiwan University, Taiwan
11 – Effect of an Aspergillus oryzae derived postbiotic on heat stress in Drosophila melanogaster and dairy cows. Ignacio Ipharraguerre, University of Kiel, Germany
12 – Influence of food matrix on prebiotic efficacy of inulin-type fructans. Peter Jackson, University of Reading, UK
13 – In silico prediction and in vitro assessment of microbial substrate utilisation among recently identified health-associated gut taxa. Cathy Lordan, University College Cork, Ireland
14 – Gamma-aminobutyric acid (GABA) production by probiotics. Andrea Monteagudo-Mera, University of Reading, UK
15 – Investigation of the Gut Microbiota Composition and Activity in Acute Myeloid Leukemic Patients: First Results of the MicroAML Study. Sarah Pötgens, Université Catholique de Louvain, Belgium
16 – Screening the prebiotic effects of human milk oligosaccharides on 330 bacterial strains derived from the infant gut microbiota. Simone Renwick, University of Guelph, Canada
17 – Integrating Dietary Data into Microbiome Studies: A Step Forward for Nutri‐Metaomics. Zaida Soler Luque, Vall d’Hebron Institute of Research, Spain
18 – Probiotic bifidobacteria mitigate the deleterious effects of para-cresol in a Drosophila melanogaster toxicity model. Gerrit Stuivenberg, Western University, Canada
19 – Development of anaerobic fermentation techniques for measuring the impact of prebiotic supplementation on human gut microbiota in clinical studies. Alexander Thorman, University of Cincinnati, USA
20 – Introducing a CRISPR-Cas9 based prime editing system for precision mutagenesis in lactobacilli. Dieter Vandenheuvel, University of Antwerp, Belgium
21 – Comparison of the effect of fidaxomicin, thuricin CD, vancomycin and nisin on the human gut microbiota, both in vitro and ex vivo. Lauren Walsh, University College Cork, Ireland
22 – Prebiotic attribute of chitin oligosaccharides derived from sea food waste. Rahul Warmoota, Panjab University Chandigarh, India
23 – FunOMIC: Pipeline with built-in Fungal Taxonomic and Functional Databases for Human Mycobiome Profiling. Xie Zixuan, Vall d’Hebron Institute of Research, Barcelona, Spain
IAC Abstracts
24 – Effects of a prebiotic soluble fiber NUTRIOSE® on intestinal immune system and gut homeostasis. Caroline Perreau, Roquette
25 – Prebiotic properties exploration of various insoluble fibers using the ex vivo SIFR® technology. Clémentine Thabuis, Roquette
26 – Structure and function of non-digestible carbohydrates in the gut microbiome. Frédérique Respondek, CP Kelco
27 – Summary of research studies revealing health-related effects of a specific prebiotic galactooligosaccharide mixture. Ged Baltulionis, Clasado Biosciences
28 – The postbiotic Lactofidus in combination with GOS/FOS prevents diarrhoea in a suckling rat model of rotavirus infection. Jan Knol, Danone Nutricia Research
29 – Long-term safety and efficacy of prebiotic intake in infants and young children. Jessica Van Harsselaar, BENEO
30 – Effect of prebiotic oligosaccharides on bowel habit and the gut microbiota in children with functional constipation: study protocol for a randomised, placebo-controlled, multi-centre trial using a validated modified Bristol Stool Form Scale. Margriet Schoterman, FrieslandCampina & Elaine Vaughan, Sensus BV
31 – Potential of pectins to modulate the human gut microbiota evaluated by in vitro fermentation: a systematic review. Nélida Pascale, CP Kelco
32 – Updated concise monograph – Dietary probiotics, prebiotics and the gut microbiota in human health. Stephan Theis, BENEO
33 – Prebiotic inulin and resistant starch mixture-specific effect on distal colonic fermentation and metabolic health. Veerle Dam, Sensus BV
34 – A Design of Experiments (DoE) approach to accelerate the optimization of viability droplet digital PCR conditions for probiotics enumeration in blends. Zhengfei Lu, Herbalife
